Showing results (501-510 of 516) with videos related to

Sort By:
Pageof 52
Molecular Biology Reports|October 24, 2020
Discovery of genomic regions and candidate genes for grain weight employing next generation sequencing based QTL-seq approach in rice (Oryza sativa L.)Reddyyamini Bommisetty, Navajeet Chakravartty, Reddaiah Bodanapu, et al.
Archives of Pathology & Laboratory Medicine|June 7, 2013
Pathologist workforce in the United States: I. Development of a predictive model to examine factors influencing supplyStanley J Robboy, Sally Weintraub, Andrew E Horvath, et al.
Nature Cancer|January 3, 2024
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapyZiyi Li, Rhea Pai, Saurabh Gupta, et al.
Molecular Neurobiology|February 21, 2025
Polypharmacology and Neuroprotective Effects of Gingerol in Alzheimer's DiseaseSakthi Priyadarshini, Keshav Goyal, Roopashree R, et al.
Journal of Cardiac Surgery|March 14, 2019
Outcomes after Ross procedure in adult patients: A meta-analysis and microsimulationSerena Sibilio, Alex Koziarz, Emilie P Belley-Côté, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma PatientsThomas Denize, Opeyemi A Jegede, Sayed Matar, et al.
Cancer Immunology Research|January 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial CancerMatthew D Galsky, Mark Kockx, Juliette Roels, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 19, 2023
Harnessing role of sesamol and its nanoformulations against neurodegenerative diseasesNavneet Singh, Sukriti Vishwas, Amandeep Kaur, et al.
Journal of Alzheimer'S Disease : JAD|April 12, 2024
Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's DiseasePunya Sachdeva, Kannan Badri Narayanan, Jitendra Kumar Sinha, et al.
The Lancet. Oncology|December 25, 2025
Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trialKarim Fizazi, Fred Saad, Teresa Alonso-Gordoa, et al.
Pageof 52